Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001181431-13-025187
Filing Date
2013-05-03
Accepted
2013-05-03 17:30:48
Documents
1
Period of Report
2013-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 3/A rrd378423.html 3/A  
1 FORM 3/A rrd378423.xml 3/A 3087
  Complete submission text file 0001181431-13-025187.txt   4445
Mailing Address 1 STULTS DRIVE PLAINSBORO NJ 08536
Business Address
CAUWENBERGH GEERT (Reporting) CIK: 0001285648 (see all company filings)

Type: 3/A | Act: 34 | File No.: 000-54910 | Film No.: 13813924

Mailing Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581
Business Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581 (508) 767-3861
RXi Pharmaceuticals Corp (Issuer) CIK: 0001533040 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations